|
1
|
Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
|
Circ Res
|
2011
|
1.00
|
|
2
|
Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
|
Biochem Pharmacol
|
2010
|
0.99
|
|
3
|
Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation.
|
Biochim Biophys Acta
|
2008
|
0.96
|
|
4
|
Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
|
Anesthesiology
|
2007
|
0.95
|
|
5
|
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.
|
J Mol Cell Cardiol
|
2010
|
0.93
|
|
6
|
{Omega}-3 and {omega}-6 polyunsaturated fatty acids block HERG channels.
|
Am J Physiol Cell Physiol
|
2005
|
0.91
|
|
7
|
Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.
|
J Gen Physiol
|
2010
|
0.89
|
|
8
|
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells.
|
PLoS One
|
2011
|
0.88
|
|
9
|
Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, alpha-linolenic acid.
|
J Mol Cell Cardiol
|
2007
|
0.85
|
|
10
|
Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries.
|
Am J Physiol Cell Physiol
|
2011
|
0.81
|
|
11
|
Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair.
|
Cardiovasc Res
|
2007
|
0.78
|
|
12
|
Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.
|
Mini Rev Med Chem
|
2010
|
0.77
|